Revision history of "Collaborative R & D project — PANTHER — THERanostic biomarkers panel)" (Q3679838)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 02:0602:06, 9 October 2024DG Regio talk contribs 68,105 bytes +2 Changed label, description and/or aliases in pt
  • curprev 02:0602:06, 9 October 2024DG Regio talk contribs 68,103 bytes +17 Set a claim value: summary (P836): O projeto PANTHER — Painel de biomarcadores THERanostic) é um projeto colaborativo de IDI de 4 anos destinado a desenvolver novos testes preditivos e prognósticos com base na avaliação de biomarcadores para medicina personalizada, especialmente em oncologia. Foi validado pelo Estado no âmbito da FUI 22 e reúne os seguintes parceiros industriais e académicos: empresas Phylogen (Dpt 30), Histalim (Dpt 34) e Laboratório de Células Circulantes Raras Hum...

20 March 2024

12 January 2024

19 June 2023

11 June 2023

8 June 2023

11 August 2022

  • curprev 16:1416:14, 11 August 2022DG Regio talk contribs 64,826 bytes +44,848 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

14 January 2022

13 January 2022

6 December 2021

1 December 2021

  • curprev 08:0908:09, 1 December 2021DG Regio talk contribs 12,988 bytes +2,337 Created claim: summary (P836): Das Projekt PANTHER – THERanostisches Biomarker-Panel) ist ein kollaboratives FuEuI-Projekt, das über 4 Jahre hinweg durchgeführt wird, um neue prädiktive und prognostische Tests zu entwickeln, die auf der Bewertung von Biomarkern für die personalisierte Medizin, insbesondere in der Onkologie, basieren. Es wurde vom Staat im Rahmen des FUI 22 validiert und umfasst die folgenden industriellen und akademischen Partner: Phylogene Unternehmen (Dpt 3...

27 November 2021

  • curprev 12:2612:26, 27 November 2021DG Regio talk contribs 10,651 bytes −2,361 Removed claim: summary (P836): Le projet PANTHER – panel de biomarqueurs à visée THERanostique)- est un projet de RDI Collaboration conduit sur 4 ans visant à développer de nouveaux tests prédictifs et pronostiques basés sur l’évaluation de biomarqueurs pour une médecine personnalisée, notamment en oncologie. Il a été validé par l’État dans le cadre du FUI 22 et regroupe les partenaires industriels et académiques suivants: entreprises Phylogène (Dpt 30), Histalim (Dpt 34),...

26 November 2021

  • curprev 23:1823:18, 26 November 2021DG Regio talk contribs 13,012 bytes +2,361 Created claim: summary (P836): Le projet PANTHER – panel de biomarqueurs à visée THERanostique)- est un projet de RDI Collaboration conduit sur 4 ans visant à développer de nouveaux tests prédictifs et pronostiques basés sur l’évaluation de biomarqueurs pour une médecine personnalisée, notamment en oncologie. Il a été validé par l’État dans le cadre du FUI 22 et regroupe les partenaires industriels et académiques suivants: entreprises Phylogène (Dpt 30), Histalim (Dpt 34), et...
  • curprev 14:5014:50, 26 November 2021DG Regio talk contribs 10,651 bytes +135 Changed label, description and/or aliases in de: translated_label

24 November 2021

18 November 2021

  • curprev 16:4516:45, 18 November 2021DG Regio talk contribs 10,085 bytes +132 Changed label, description and/or aliases in en: translated_label
  • curprev 16:4516:45, 18 November 2021DG Regio talk contribs 9,953 bytes +2,085 Created claim: summary (P836): The PANTHER project — THERanostic biomarkers panel)- is a 4-year collaborative RDI project aimed at developing new predictive and prognostic tests based on the evaluation of biomarkers for personalised medicine, especially in oncology. It has been validated by the State under FUI 22 and brings together the following industrial and academic partners: companies Phylogen (Dpt 30), Histalim (Dpt 34), and the Laboratory of Human Rare Circulating Cell...

17 November 2021